AURAK
29.9.2018 10:40:05 CEST | Business Wire | Press release
The American University of Ras Al Khaimah (AURAK) ranked twelfth among 103 UAE institutions with Scopus affiliations, with a total of 403 Scopus documents published by the AURAK faculty and researchers.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180929005009/en/
Scopus is the largest database of peer-reviewed literature, encompassing scientific journals, books, and conference publications. The extensive global scholarship indexed in Scopus includes research in science, arts and humanities, social sciences, medicine, and technology. A high ranking in Scopus is understood by many to be one of the top indicators of excellence in research worldwide.
AURAK is a public non-profit, independent, coeducational institution of higher education, which provides an integrated North American-style education. It is accredited by the Ministry of Education in the UAE and offers twenty-two undergraduate and graduate programs across a wide range of disciplines. In September 2017 AURAK stood at the 24th position out of 98 institutions with Scopus affiliations in the UAE, with 249 Scopus publications. Within a period of one year there has been a 62 percent increase in Scopus publications with the 2018 ranking, with AURAK climbing the competitive ladder to the twelfth slot out of 103 institutions, and with the faculty publishing 403 Scopus documents. With its prodigious rate of quality publications, AURAK has risen higher in the rankings even with increased numbers of competitors in the field.
The Provost, Professor Stephen Wilhite, observed that faculty engagement in research is fundamental the university’s achievement of its mission to exemplify the highest standards of teaching and research. “As accomplished researchers, faculty members model for their student’s active engagement in advancing knowledge in their discipline.”
AURAK President, Professor Hassan Al Alkim, is elated with the hard work and progress of his faculty, “This type of results supports our claim that our faculty is not only certified, but is comprised of highly qualified professionals that are on the forefront of contemporary research and that our institution is indeed highly competitive among the leading Arabic institutions in the UAE. Not only did our institution improve its status from last year, but it did so even in a broader, more competitive atmosphere. Our students are receiving a first-rate education from first-rate professors who are highly active in the academic world of research and on the cutting edge of innovative ideas.”
*Source: AETOSWire
View source version on businesswire.com: https://www.businesswire.com/news/home/20180929005009/en/
Contact:
AURAK Jessica Zani , +97172210900 Ext: 1325 jessica.zani@aurak.ac.ae
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Carnegie Mellon University and Cleveland Clinic Develop AI System to Interpret Cardiac MRI Scans with Enhanced Accuracy21.5.2026 14:05:00 CEST | Press release
Trained on more than 13,000 patient studies, novel system significantly outperforms existing models by up to 35% A team of researchers from Carnegie Mellon University, in collaboration with Cleveland Clinic’s Cardiovascular Innovation Research Center, has developed an artificial intelligence (AI) system capable of interpreting some of the most complex heart scans in medicine, cardiac magnetic resonance imaging (MRI), without the need for manually labeled training data. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521762286/en/ A team of researchers from Carnegie Mellon University, in collaboration with Cleveland Clinic’s Cardiovascular Innovation Research Center, has developed an artificial intelligence (AI) system capable of interpreting some of the most complex heart scans in medicine, cardiac magnetic resonance imaging (MRI), without the need for manually labeled training data. The novel system, called CMR-CLIP, is d
Otovo Hits 30,000 Customers in Under a Year, Tackling the Growing ‘Solar Service Crisis’21.5.2026 14:00:00 CEST | Press release
A growing wave of unsupported solar systems and rising electricity prices are creating strong demand for Otovo’s energy service platform Otovo ASA (“Otovo”), a leading global energy service provider for residential and commercial customers, today announced it has reached 30,000 customers across the U.S. and Europe. A total of 20,000 customers have enrolled in Otovo Care, the Company’s membership-based home and commercial energy service, which is powered by Otovo’s industry-leading AI platform, Endurance™. “Reaching 30,000 customers in less than year is proof positive that home and business owners value their power systems,” said William J. (John) Berger, CEO of Otovo. “The ‘solar service crisis’ that is leaving millions of orphaned energy systems without support is driving strong interest in our Otovo Care membership program. Every day your home or commercial power system is not working, you are throwing money away. Otovo’s rapid response service platform keeps you up and running, ensu
The Live Moment Effect: Genius Sports and MediaScience Study Finds Specific Moments in Live Sports Can Double Unaided Brand Recall21.5.2026 14:00:00 CEST | Press release
New research shows that brands aligned with emotionally heightened moments in live sports can improve ad effectiveness Genius Sports Limited (NYSE: GENI), a global leader in real-time sports data, today released new biometric research conducted with MediaScience showing that ads delivered immediately after emotionally heightened moments in live sports can double unaided brand recall. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521475265/en/ The Live Moment Effect report from Genius Sports and MediaScience. The study, The Live Moment Effect, finds that advertising effectiveness is significantly influenced by a viewer’s emotional state immediately before an ad is shown. In controlled biometric testing, ads shown after high-intensity sporting moments, such as near-scoring plays or crucial momentum shifts, delivered approximately double the unaided brand recall of baseline conditions. The Moment Before the Ad Matters The r
Merck Announces First Patient Dosed in Phase 3 Study for Investigational Antibody-Drug Conjugate in Colorectal Cancer21.5.2026 14:00:00 CEST | Press release
Precemtabart tocentecan (Precem-TcT) is investigated as a potential first-in-class anti-CEACAM5 ADC, for the treatment of metastatic CRC (mCRC) CEACAM5 is overexpressed in the majority of colorectal tumors (~90%), and requires no patient selection Significant unmet need remains for clinically meaningful innovation in colorectal cancer (CRC), the second leading cause of cancer death worldwide Not intended for Canada-, UK- or US-based media Merck, a leading science and technology company, today announced that the first patient has been dosed in the Phase 3 PROCEADE®-CRC-03 trial (NCT07549412). The study is evaluating precemtabart tocentecan (Precem‑TcT), a potential first‑in‑class investigational anti‑CEACAM5 antibody‑drug conjugate (ADC), for the treatment of metastatic colorectal cancer (mCRC). “Leveraging our novel payload‑linker technology, Precem‑TcT is the first CEACAM5‑targeted ADC in clinical studies with an exatecan payload, rationally designed for stability and enhanced cancer
Baszucki Group Funds Oxford University Clinical Trial of Ketogenic Therapy for Early Psychosis21.5.2026 13:00:00 CEST | Press release
Randomized controlled trial will evaluate both symptom progression and underlying biology Baszucki Group today announced a £1.17 million grant to support a randomized controlled trial at the University of Oxford assessing the feasibility, safety, and efficacy of a ketogenic diet for patients at clinical high risk of psychosis (CHR-P). Researchers will test this nutritional therapy's ability to improve patients' mental and physical health. This project builds on a growing body of research suggesting the potential of metabolic therapies in treating serious mental illness. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521877110/en/ Baszucki Group Funds £1.17 Million for University of Oxford Trial of Ketogenic Therapy for Early Psychosis Psychotic disorders carry a massive personal burden and are associated with a lower life expectancy. Psychosis does not develop immediately, but typically emerges following a period of early
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom